Search

Your search keyword '"Diuretics urine"' showing total 234 results

Search Constraints

Start Over You searched for: Descriptor "Diuretics urine" Remove constraint Descriptor: "Diuretics urine"
234 results on '"Diuretics urine"'

Search Results

1. Elimination profile of low-dose chlortalidone and its detection in hair for doping analysis-Implication for unintentional non-therapeutic exposure.

2. Highly sensitive voltammetric determination of hydrochlorothiazide using a glassy carbon electrode modified with Super P carbon black nanoparticles.

3. A comprehensive and high-throughput screening method for multiple prohibited substances by UPLC-QE Plus-HRMS and HPLC-QQQ-MS in human urine for doping control.

4. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence.

5. A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section.

6. Rats with congenital hydronephrosis show increased susceptibility to renal ischemia-reperfusion injury.

7. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.

8. Determination of diuretics in human urine using HPLC coupled with magnetic solid-phase extraction based on a metal-organic framework.

9. A biochemometrics strategy for tracing diuretic components of crude and processed Alisma orientale based on quantitative determination and pharmacological evaluation.

10. Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplements.

11. Identification and confirmation of diuretics and masking agents in urine by turbulent flow online solid-phase extraction coupled with liquid chromatography-triple quadrupole mass spectrometry for doping control.

12. Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.

13. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.

14. Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses.

15. High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis.

16. Reference values of renal tubular function tests are dependent on age and kidney function.

17. Two-phase and three-phase liquid-phase microextraction of hydrochlorothiazide and triamterene in urine samples.

18. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.

19. Analytical development of a binuclear oxo-manganese complex bio-inspired on oxidase enzyme for doping control analysis of acetazolamide.

20. Electrochemical investigation of the voltammetric determination of hydrochlorothiazide using a nickel hydroxide modified nickel electrode.

21. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.

22. Perinatal growth restriction decreases diuretic action of furosemide in adult rats.

23. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis.

24. Population-based meta-analysis of furosemide pharmacokinetics.

25. Simultaneous determination of aliskiren and hydrochlorothiazide in tablets and spiked human urine by ion-pair liquid chromatography.

26. Population-based meta-analysis of hydrochlorothiazide pharmacokinetics.

27. Determination of torasemide by fluorescence quenching method with some dihalogenated fluorescein dyes as probes.

28. Magnetic resonance imaging finding of empty sella in obesity related idiopathic intracranial hypertension is associated with enlarged sella turcica.

29. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.

30. A sensitive spectrofluorometric method for determination of ergosta-4,6,8(14),22-tetraen-3-one in rat plasma, feces, and urine for application to pharmacokinetic studies using cerium(III) as a probe.

31. The effective method for investigation meridian tropism theory in rats.

32. Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects.

33. Matrix effect marker for multianalyte analysis by LC-MS/MS in biological samples.

34. Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control.

35. 'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry.

36. Synthesis and in vivo diuretic activity of some novel pyrimidine derivatives.

37. Pharmacokinetics, pharmacodynamics and safety of tolvaptan, a novel, oral, selective nonpeptide AVP V2-receptor antagonist: results of single- and multiple-dose studies in healthy Japanese male volunteers.

38. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.

39. Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine.

40. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.

41. Simultaneous extraction and screening of diuretics, beta-blockers, selected stimulants and steroids in human urine by HPLC-MS/MS and UPLC-MS/MS.

42. Micellar liquid chromatography in doping control.

43. [Detection of selected diuretics in biological fluids by chromatography mass spectrometry].

44. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection.

45. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.

46. A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.

47. Stability of selected chlorinated thiazide diuretics.

48. Sample preparation development and matrix effects evaluation for multianalyte determination in urine.

49. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS.

50. Determination of diuretics in human urine by hollow fiber-based liquid-liquid-liquid microextraction coupled to high performance liquid chromatography.

Catalog

Books, media, physical & digital resources